全部资讯｜CELL INTELLIGENCE

Recent advances in cell therapy for AML/MDS.

PubMed 2026/09/04 发表Int J HematolQ3 · IF 1.9（JCR 2025）

Overcoming Resistance and Relapse in CAR-T and CAR-NK Cell Therapies: From Bench to Bedside.

PubMed 2026/01/05 发表Research (Wash D C)Q1 · IF 12.9（JCR 2025）

2025 Update of Cellular Immunotherapy for Plasma Cell Disorders.

PubMed 2025/12/23 发表Turk J HaematolQ3 · IF 1.6（JCR 2025）

Tumor-priming CD8(+) natural killer T-like cells as an efficient novel cell therapy for relapsed/refractory multiple myeloma.

PubMed 2025/09/29 发表Exp Hematol OncolQ1 · IF 17.5（JCR 2025）

TPNC 是一种通过肿瘤驱动的致敏产生的新型细胞毒性淋巴细胞产品。

CAR-NK Cells Generated with mRNA-LNPs Kill Tumor Target Cells In Vitro and In Vivo.

PubMed 2023/08/29 发表Int J Mol SciQ1 · IF 5.6（JCR 2025）

Relapsed/refractory diffuse large B cell lymphoma with cardiac involvement: A case report and literature review.

PubMed 2023/01/30 发表Front OncolQ2 · IF 3.4（JCR 2025）

本例患者的应答凸显了早期诊断与及时治疗对改善 SCL 预后的重要性，并为 SCL 治疗策略提供了重要参考。

Adoptive Cellular Therapy in Acute Myeloid Leukemia: Current Scope and Challenges.

PubMed 2022/12/15 发表Hematol Oncol Stem Cell Ther

全部资讯 7